Oral semaglutide missed its primary endpoint for drinking. The VA’s new 622-person phase 3 is built on the one result that trial failed to get.
Both drugs block PCSK9 and cut LDL by about the same amount. Repatha is available now and cheap for most insured people. Lipfendra saves you the needle but asks for a daily fasting window, and its only published price is a list price.
The fight that decides what you will pay for the strongest obesity drug yet seen in large trials comes down to a single amino acid, and nobody has won it yet.
The FDA’s compounding committee voted on seven peptides, recommending BPC-157. What peptides are, why the market exploded, and what the vote does and does not decide.
My TRT clinic prescribed 5 mg of tadalafil a day. Here is what it is actually proven to do for the prostate and ED, what the podcasts oversell, and the one drug interaction to never ignore.
A single low testosterone reading isn’t a diagnosis. I’m on TRT, and here’s how low testosterone is actually diagnosed, what TRT does, and the fertility risk young men miss.
I take a diabetes drug and have never had diabetes. A plain-English map of the type 2 diabetes drugs, and why the best ones now protect your heart and kidneys, not just blood sugar.
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor. What it costs, how the pill compares to the shots, and who actually needs it.
A cyclospora outbreak just sickened 1,645 people across 34 states, and romaine keeps causing E. coli recalls. Is romaine lettuce safe to eat, and is it even worth it? A hard look, and what I eat instead.
Finding purpose in retirement is the part no one plans for. Why a project beats a blank calendar, what the research on hobbies and mattering shows, and how to start before you retire.
